Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-23-047712)

Filing Details

Accession Number:: 0000950170-23-047712
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-12 16:07:40
Reporting Period:: 2023-09-12

Accepted Time:: 2023-09-12 16:07:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1503802	Karyopharm Therapeutics Inc.	KPTI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1254705	G Garen Bohlin	C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-12	41,140	$1.22	45,140	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price..